As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

A lawsuit filed by the Cabell County Commission and the City of Huntington against some of the country’s biggest drug ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine. The lawsuit, filed ...

The program, called 340b, allows eligible safety net providers to purchase drugs at deeply discounted prices, then reinvest ...